41127100

Nom de l'organisation

Penta Arzneimittel GmbH

SRN

DE-MF-000006565

Statut du fabricant

Actif

12 avertissements enregistrés — faire défiler le panneau pour tout voir.

• CW007

  Do not use the product if the safety ring of the tamper evident closure is broken or the bottle is damaged.
• CW032

  Do not use the eye drops beyond the expiry date which you can find on each multi-dose container and on the folding box.
• CW010

  Consult instructions for use.
• CW036

  If you also use other eye drops / eye ointment, wait about 15 minutes. These eye drops should always be used last. Contact lenses must be removed before use and can be reinsert not earlier than 15 minutes after application.
• CW999

  Due to the special innovative sterile filter system of the dropper insert a small quantity always remains in the bottle. To ensure unrestricted dropping capability, regular use is recommended.
• CW135

  Please keep the product out of reach of children.
• CW137

  Do not use in infected or injured eyes. Important information for users with severe corneal damage: In very rare cases, deposits of calcium phosphate on the cornea have been reported during the use of phosphate-containing eye drops.
• CW008

  Do not touch the eye with the dropper.
• CW129

  Do not use if you are allergic to any of the ingredients.
• CW304

  In very rare cases, the use of the eye drops may cause irritation in very sensitive eyes or eye lids. The following eye disorders may occur: redness, pain, burning, stinging, itching, swelling, foreign body sensation.
• CW011

  Temporary blurring for a brief period may be experienced after application; avoid driving, operating machinery and wait until normal vision is restored.
• CW277

  In case a serious incident has occurred during the use of this medical device or as a result of its use, please report it to the manufacturer and the competent authority.

Marché principal en Tchéquie ; disponible dans 2 pays au total.

Dénomination commerciale

non renseigné

Code d'UDI-DI

14260595532819

Basic UDI-DI

426059553MP27OSD012K

Numéro de référence/catalogue

41127100

Entité d'attribution

GS1

Catégorie de risque

Classe IIb

Législation applicable

MDR [Règlement (UE) 2017/745 relatif aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

Sodium Hyaluronate - Patent Blue V Eye Drops (multi dose container, 10ml) care for and moisturise the ocular surface and alleviate the symptoms of Dry Eye Syndrome and reduce slight redness and yellowish discolouration in the eye.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• Q02030301OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES